BB Biotech AG (BION.S)
BION.S on Swiss Exchange
68.55CHF
24 May 2019
68.55CHF
24 May 2019
Change (% chg)
CHF0.05 (+0.07%)
CHF0.05 (+0.07%)
Prev Close
CHF68.50
CHF68.50
Open
CHF68.65
CHF68.65
Day's High
CHF69.55
CHF69.55
Day's Low
CHF68.40
CHF68.40
Volume
48,615
48,615
Avg. Vol
82,532
82,532
52-wk High
CHF74.60
CHF74.60
52-wk Low
CHF55.05
CHF55.05
About
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)
Overall
| Beta: | 1.14 |
| Market Cap(Mil.): | CHF3,794.90 |
| Shares Outstanding(Mil.): | 55.40 |
| Dividend: | 3.05 |
| Yield (%): | 4.82 |
Financials
| BION.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 9.66 | 94.22 | 35.45 |
| EPS (TTM): | 7.09 | -- | -- |
| ROI: | 11.17 | 7.58 | 11.75 |
| ROE: | 11.17 | 8.15 | 16.50 |
BRIEF-BB Biotech Q1 Profit Of CHF 890 Million
* Q1 PROFIT OF CHF 890 MN (PROFIT OF CHF 28 MN IN CORRESPONDING PERIOD OF PREVIOUS YEAR) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Swiss stocks - Factors to watch on April 12
ZURICH/BERLIN, April 12 The Swiss blue-chip SMI was seen opening 0.1 percent lower at 9,543 points on Friday, according to premarket indications by bank Julius Baer .
BRIEF-BB Biotech Launches New Buyback Program
* SAID ON THURSDAY CONCLUDES ITS SHARE BUYBACK PROGRAM AND LAUNCHES A NEW BUYBACK PROGRAM
BRIEF-BB Biotech FY Net Result Swings To Loss Of CHF 471 Million
* FY NET LOSS OF CHF 471 MN COMPARED TO A NET GAIN OF CHF 688 MN FOR FULL YEAR OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
BRIEF-BB Biotech FY Net Result Swings To Loss Of CHF 471 Million
* BB BIOTECH INVESTS GAINS OF M&A TRANSACTIONS IN NEW TECHNOLOGIES - DIVIDEND OF CHF 3.05 PROPOSED
Estimates